|Bid||449.50 x 0|
|Ask||453.50 x 0|
|Day's range||444.98 - 457.50|
|52-week range||276.62 - 870.00|
|Beta (5Y monthly)||1.03|
|PE ratio (TTM)||22.47|
|Earnings date||18 Apr 2023 - 24 Apr 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||1,070.29|
Oxford Biomedica plc ( LON:OXB ) shareholders should be happy to see the share price up 26% in the last quarter. But...
How far off is Oxford Biomedica plc ( LON:OXB ) from its intrinsic value? Using the most recent financial data, we'll...
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018). Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain. Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer Oxford, UK – 22